ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

4 links0 made here, not in the record17 judgments1 judge (the rules as one: Rule based)3 record changes seen
Rule basedRecord updated on ClinicalTrials.gov
Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07863167An Open, Multicenter PhaseII Clinical Trial ofSHR-A2009 Combined WithOther Anti-tumor Therapiesfor Perioperative Treatmentof Resectable Non-smallCell Lung Cancer.Suzhou Suncadia BiopharmaceutiPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 7 · ClinicalTrials.gov record · Version of 2026-10-07Nov 9 · ClinicalTrials.gov record · Version of 2026-11-09Nov 18 · ClinicalTrials.gov record · Version of 2026-11-18Version of 2026-11-18CONDITIONSCarcinoma, Non-Small-Cell L…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionDRUGSAdebrelimabEntry “adebrelimab + SHR-A2009”, read…›As of now · Rule based · TestedAs of now · Rule based · TestedAs of now · Rule based · TestedAs of now · Rule based · ComparatorComparatorRuzaltatug rezetecanEntry “adebrelimab + SHR-A2009”, read…›As of now · Rule based · TestedAs of now · Rule based · TestedAs of now · Rule based · TestedAs of now · Rule based · TestedAs of now · Rule based · TestedAs of now · Rule based · TestedTestedAumolertinibEntry “almonertinib combined with SHR…›As of now · Rule based · TestedAs of now · Rule based · TestedAs of now · Rule based · TestedAs of now · Rule based · TestedAs of now · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Carcinoma, Non-Small-Cell Lung

From the registry record2 judgments on this link
Kind of condition link, from the registry to what was judged
RegistryCarcinoma, Non-Small-Cell Lung, as filedthe registry files the study under it
→judged
Main condition (R9)

All judgments on this study

WhenLinkJudgeDecisionState
Oct 7The record itselfClinicalTrials.gov recordVersion of 2026-10-07Record change
Nov 9The record itselfClinicalTrials.gov recordVersion of 2026-11-09Record change
Nov 14Carcinoma, Non-Small-Cell LungRule based · condition-kind ruleFinest filed termCurrent
Nov 18The record itselfClinicalTrials.gov recordVersion of 2026-11-18Record change
As of nowCarcinoma, Non-Small-Cell LungRule based · main-condition ruleMain conditionCurrent
As of nowAdebrelimabRule based · role ruleTestedCurrent
As of nowAdebrelimabRule based · role ruleTestedCurrent
As of nowAdebrelimabRule based · role ruleTestedCurrent
As of nowAdebrelimabRule based · role ruleComparatorCurrent
As of nowRuzaltatug rezetecanRule based · role ruleTestedCurrent
As of nowRuzaltatug rezetecanRule based · role ruleTestedCurrent
As of nowRuzaltatug rezetecanRule based · role ruleTestedCurrent
As of nowRuzaltatug rezetecanRule based · role ruleTestedCurrent
As of nowRuzaltatug rezetecanRule based · role ruleTestedCurrent
As of nowRuzaltatug rezetecanRule based · role ruleTestedCurrent
As of nowAumolertinibRule based · role ruleTestedCurrent
As of nowAumolertinibRule based · role ruleTestedCurrent
As of nowAumolertinibRule based · role ruleTestedCurrent
As of nowAumolertinibRule based · role ruleTestedCurrent
As of nowAumolertinibRule based · role ruleTestedCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.